Imagen de Portada
Código QR

SAKK 06/19: rBCG added to chemo-IO achieves high pCR in MIBC.

Publicado en:Urology Times Vol. 54; no. 5; pp. 23 - 25
Autor principal: SAYLOR, BENJAMIN P.
Formato: pictorial Journal Article
Publicado: MJH Life Sciences Jul/Aug2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195314686&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 195314686
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00939722
        URO
      jtl: Urology Times
      issn: 00939722
      maglogo: N
    pubinfo:
      dt: Jul/Aug2026
      vid: 54
      iid: 5
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        195314686
        195314686
        195314686
        195314686
      ppf: 23
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: SAKK 06/19: rBCG added to chemo-IO achieves high pCR in MIBC.
      aug:
        au: SAYLOR, BENJAMIN P.
      sug:
        subj:
          Administration, Intravesical
          BCG Vaccine Therapeutic Use
          Chemotherapy, Cancer
          Immunotherapy
          Bladder Neoplasms Drug Therapy
          Pathologic Complete Response
          Antineoplastic Agents, Combined Therapeutic Use
          American Society of Clinical Oncology
          Overall Survival
          Disease-Free Survival
          Patient Safety
          Cancer Patients
      pubtype: Academic Journal
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N